NASDAQ:CALC

CalciMedica (CALC) Stock Price, News & Analysis

CalciMedica logo
$1.17 -0.05 (-4.10%)
Closing price 04:00 PM Eastern
Extended Trading
$1.16 -0.01 (-0.85%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About CalciMedica Stock (NASDAQ:CALC)

Advanced

Key Stats

Today's Range
$1.15
▼
$1.22
50-Day Range
$1.02
▼
$2.30
52-Week Range
$1.00
▼
$36.00
Volume
33,644 shs
Average Volume
172,136 shs
Market Capitalization
$8.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$50.00
Consensus Rating
Hold

Company Overview

CalciMedica is a clinical-stage biopharmaceutical company developing treatments for serious inflammatory and immunologic conditions. Its research focuses on calcium release-activated calcium (CRAC) channels, which play a role in immune-cell activity and inflammation.

The company’s lead drug candidate, Auxora, is an investigational CRAC channel inhibitor being studied for acute inflammatory conditions, including acute pancreatitis. CalciMedica has no marketed products; its candidates remain in clinical development.

Based in La Jolla, California, CalciMedica became a publicly traded company in 2024 through a business combination with Orion Acquisition Corp. The company’s work is centered on developing and testing its therapies, rather than commercial product sales.

AI Generated. May Contain Errors.

CalciMedica Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

CALC MarketRank™: 
2.663775850565 of 5 stars

CalciMedica scored higher than 53% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CalciMedica has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on no strong buy ratings, 2 buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    CalciMedica has a consensus price target of $50.00, representing about 4,173.5% upside from its current price of $1.17.

  • Amount of Analyst Coverage

    CalciMedica has only been the subject of 2 research reports in the past 90 days.

  • Read more about CalciMedica's stock forecast and price target.
  • Earnings Growth

    Earnings for CalciMedica are expected to grow in the coming year, from ($1.93) to ($1.61) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CalciMedica is -0.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CalciMedica is -0.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    CalciMedica has a P/B Ratio of 1.92. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.50% of the float of CalciMedica has been sold short.
  • Short Interest Ratio / Days to Cover

    CalciMedica has a short interest ratio ("days to cover") of 1.78, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CalciMedica has recently increased by 178.04%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    CalciMedica does not currently pay a dividend.

  • Dividend Growth

    CalciMedica does not have a long track record of dividend growth.

  • News Sentiment

    CalciMedica has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for CalciMedica this week, compared to 2 articles on an average week.
  • Search Interest

    Only 4 people have searched for CALC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CalciMedica insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    28.25% of the stock of CalciMedica is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    CalciMedica has minimal institutional ownership at this time.

  • Read more about CalciMedica's insider trading history.
Receive CALC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CalciMedica and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CALC Stock News Headlines

FY2026 EPS Estimates for CalciMedica Raised by HC Wainwright
ELON + YOU + DECEMBER 8TH
Elon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th. A free Masterclass claims to reveal what Musk filed with regulators and why he's working to keep it quiet.tc pixel
CalciMedica (CALC) Set to Release Earnings on Wednesday
CalciMedica (CALC) Stock Forecast & Price Target
See More Headlines

CALC Stock Analysis - Frequently Asked Questions

CalciMedica's stock was trading at $32.95 at the beginning of 2026. Since then, CALC shares have decreased by 96.4% and is now trading at $1.17.

CalciMedica Inc. (NASDAQ:CALC) announced its quarterly earnings results on Tuesday, November, 10th. The company reported ($0.24) EPS for the quarter, beating analysts' consensus estimates of ($1.27) by $1.03.

CalciMedica's stock reverse split on Monday, August 31st 2026.A 1-5 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, August 30th 2026. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

CalciMedica (CALC) raised $90 million in an initial public offering on Friday, September 25th 2020. The company issued 5,625,000 shares at $15.00-$17.00 per share.

Shares of CALC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/10/2026
Today
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:CALC
CIK
1534133
Fax
N/A
Employees
12
Year Founded
2007

Price Target and Rating

High Price Target
$50.00
Low Price Target
$50.00
Potential Upside/Downside
+4,173.5%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.44)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$29.56 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-4,239.00%
Return on Assets
-151.02%

Debt

Debt-to-Equity Ratio
1.63
Current Ratio
4.96
Quick Ratio
4.96

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.61 per share
Price / Book
1.92

Miscellaneous

Outstanding Shares
6,900,000
Free Float
4,947,000
Market Cap
$8.07 million
Optionable
No Data
Beta
0.84

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:CALC) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners